+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07551609

Evaluation of RRS4 HA Long Lasting Device for Treating Facial Wrinkles and Skin Quality in Adults

Led by Skin Tech Pharma Group S.L.U. · Updated on 2026-09-15

207

Participants Needed

6

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the clinical performance and long-term safety of the CE-marked RRS4 HA Long Lasting device for treating skin photoaging in healthy adults. The study focuses on improving facial wrinkles and overall skin quality by comparing the treated group with an untreated control group. The main goal is to determine the proportion of participants with significant wrinkle improvement at 2 months and assess photodamage changes. Participants are randomly assigned in a 21 ratio to receive either the RRS4 HA Long Lasting treatment or no treatment. The treatment involves a single injection on Day 0, with some participants eligible for a second touch-up injection on Day 30 based on wrinkle improvement evaluation. The device is a sterile dermal implant containing cross-linked, resorbable hyaluronic acid. Throughout the study, participants attend follow-up visits at baseline, 1 month, 2, 3, and 6 months. Researchers assess wrinkle severity, photodamage, skin texture, hydration, and global aesthetic improvement. Satisfaction of both subjects and investigators is measured at 6 months. The presence of the product in tissue is monitored before and after injection and at 6- and 12-month follow-ups. The total study duration extends up to 12 months with safety and efficacy evaluations.

CONDITIONS

Brief Title

Study of RRS® HA Long Lasting for Improving Facial Wrinkles and Skin Quality

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here